Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease
Journal of Global Health · 2026
DOI: 10.7189/jogh.16.04311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, 2026. Verfasst von Jing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Diabetic Retinopathy. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Background
Diabetic retinopathy (DR) and Alzheimer disease (AD) share metabolic and vascular dysfunctions, but the extent to which they reflect overlapping genetic susceptibility and neurovascular-metabolic regulatory pathways remains unclear. We combined multi-omics analyses with population-based data to examine the genetic convergence, cellular pathways, and longitudinal association between DR and AD.
Methods
We performed a two-sample Mendelian randomisation (MR) to estimate the association between genetically predicted DR liability and AD risk. We used Bayesian colocalisation analysis to identify shared genomic loci, and summary-data-based MR (SMR) to detect expression-mediated genes jointly associated with DR and AD. We analysed single-cell RNA sequencing data to characterise shared cellular features and related biological pathways. We also conducted an MR-based mediation analysis to explore whether lipid-related, metabolic, or inflammatory traits mediated the observed DR-AD association, and a longitudinal analysis of the UK Biobank cohort to assess the association between DR and incident AD.
Results
With the MR analysis, we found that genetically predicted liability to DR was associated with a modest increase in AD risk. Colocalisation analysis supported a shared genetic signal. We identified three genes with shared expression-mediated associations across DR and AD through SMR. Functional enrichment analyses revealed partially overlapping neurovascular and metabolic pathways. Using MR-based mediation analysis, we found no significant intermediary traits linking DR and AD. Findings from the UK Biobank cohort were directionally consistent with the genetic analyses.
Conclusions
Genetic liability to DR is associated with an increased risk of AD and is accompanied by shared expression-mediated effects and convergent neurovascular-metabolic pathways. These findings support the possibility that DR may serve as a clinically accessible indicator of increased neurodegenerative vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai, China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ophthalmology, General Hospital of Ningxia Medical University, Yinchuan, China.
Zitieren
APA
Li, J., Liu, Q., Ma, Q., Shen, T., Xia, J., Yang, X., Liu, K., Li, N., & Yan, B. (2026). Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease. Journal of Global Health. https://doi.org/10.7189/jogh.16.04311
Vancouver
Li J, Liu Q, Ma Q, Shen T, Xia J, Yang X, et al. Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease. Journal of Global Health. 2026. doi:10.7189/jogh.16.04311
BibTeX
@article{Li2026,
author = {Li, Jing and Liu, Qian and Ma, Qian and Shen, Ting and Xia, Jiao and Yang, Xiongyi and Liu, Kun and Li, Na and Yan, Biao},
title = {Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease},
journal = {Journal of Global Health},
year = {2026},
doi = {10.7189/jogh.16.04311}
}
EUVIMED